Thursday, May 19, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



China approves new vaccine amid new Covid-19 outbreak

China approves new vaccine amid new Covid-19 outbreak

Beijing, May 15 (Prensa Latina) China approved the emergent use of its sixth Covid-19 vaccine, amid the fight against a new outbreak of this disease, which has resulted in 10 cases so far.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The regulators approved the vaccine from the pharmaceutical company Shenzhen Kangtai Biological Products, which is currently in the last phase of clinical trials.

Between December, 2020, and May, 2021, the government authorized four vaccines developed by Sinopharm, Sinovac, CanSino and the Institute of Microbiology from the Science Academy, and all are being used in the current vaccination campaign.

China approved the new vaccine amid its fight against the new Covid-19 outbreak in the provinces of Anhui (east) and Liaoning (northeast), with measures such as the designation of several neighborhoods in the medium-risk category, mass health check-ups and disinfection of public places.

Together, specialists from the National Health Commission are investigating the source of transmission of the SARS-CoV-2 coronavirus, which causes the disease. The situation in Anhui and Liaoning broke China’s streak of 20 consecutive days without reporting local Covid-19 cases.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.